Hardev Pandha

16.2k citations

223 papers · 7.8k indexed · h-index 50

Impact in

Genetics top 0.2%
- Virus-based gene therapy research
Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Biotechnology 47
- Cancer Research and Treatments 47
Genetics 105
- Virus-based gene therapy research 95

Co-authors: Kevin J. Harrington Alan Melcher Richard G. Vile Richard Morgan Fiona Errington‐Mais Matt Coffey Agnieszka Michael Peter J. Selby
Journals: Clinical Cancer Research (19 papers)Journal of Clinical Oncology (17 papers)Molecular Therapy (12 papers)BMC Cancer (7 papers)Gene Therapy (7 papers)
Partner nations: United Kingdom United States Canada

In The Last Decade

Hardev Pandha

220 papers receiving 7.6k citations

Peers

Countries citing papers authored by Hardev Pandha

Since Specialization

Citations

This map shows the geographic impact of Hardev Pandha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hardev Pandha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hardev Pandha more than expected).

Fields of papers citing papers by Hardev Pandha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hardev Pandha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hardev Pandha. The network helps show where Hardev Pandha may publish in the future.

Co-authors

The 25 scholars most cited alongside Hardev Pandha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hardev Pandha Line = papers co-authored together Hardev Pandha links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer Cells ·禺彦東, Christopher D. Smith, Gabriel Hideki Vatanabe Brunello, Mohammad Asim, Hardev Pandha, Yuzhuo Wang	2024	3
2	A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer Frontiers in Oncology ·中島秀紀, Huahua Su, 禺彦東, Christopher P. Smith, Damir Devetak, Hardev Pandha, Mohammad Asim	2023	16
3	Multi-omic diagnostics of prostate cancer in the presence of benign prostatic hyperplasia Heliyon ·Matt Spick, دکتر پروین شکور, Hardev Pandha, Agnieszka Michael, Lee A. Gethings, Christopher J. Hughes, 张开金, Robert S. Plumb, Ian D. Wilson, Anthony D. Whetton, Paul A. Townsend, Nophar Geifman	2023	7
4	Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance ChemMedChem ·伸之滝, 禺彦東, Nathan Harpham, Jessica Iegre, Hardev Pandha, Mohammad Asim, David R. Spring	2022	6
5	Breaking androgen receptor addiction of prostate cancer by targeting different functional domains in the treatment of advanced disease Translational Oncology ·禺彦東, Susan Vaught, Hardev Pandha, Mohammad Asim	2021	14
6	Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib British Journal of Urology ·Guillermo de Velasco, A Editoria, Òscar Reig, Francesco Massari, Miguel Á. Climent Durán, Elena Verzoni, Jeffrey Graham, Roberto Llarena, Michele De Tursi, Frede Donskov, Yupei Du, Hardev Pandha, Xavier García del Muro, Giuseppe Procopio, Stéphane Oudard, Daniel Castellano, Laurence Albigès	2021	2
7	Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies Journal for ImmunoTherapy of Cancer ·Victoria Roulstone, David Mansfield, R. J. C. Harris, Katie Twigger, Christine White, Johann S. de Bono, James Spicer, Sophia N. Karagiannis, Richard G. Vile, Hardev Pandha, Alan Melcher, Kevin J. Harrington	2021	10
8	The Role of Circular RNAs in Pancreatic Ductal Adenocarcinoma and Biliary-Tract Cancers Cancers ·Christopher Limb, Daniel Liu, Morten T. Venø, 小川和紀, Jonathan Krell, Izhar Bagwan, Elisa Giovannetti, Hardev Pandha, Oliver Strobel, Timothy Rockall, Adam E. Frampton	2020	22
9	Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment Cancer Immunology Research ·Laura Evgin, Amanda L. Huff, Timothy Kottke, Jill Thompson, Amy M. Molan, Christopher B. Driscoll, Matthew Schuelke, Kevin G. Shim, Phonphimon Wongthida, Elizabeth J. Ilett, R Guillot, Reuben S. Harris, Matt Coffey, José S. Pulido, Hardev Pandha, Peter J. Selby, Kevin J. Harrington, Alan Melcher, Richard G. Vile	2019	13
10	Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer Clinical Cancer Research ·Nicola Annels, David Mansfield, 조행래, Carmen Ballesteros‐Merino, Guy R. Simpson, R. U. Gooding, JULIA CAIRA, Alan Melcher, Kevin J. Harrington, B. Švárová, Gough G. Au, Mark Grose, Izhar Bagwan, Bernard A. Fox, Richard G. Vile, Hugh Mostafid, Darren R. Shafren, Hardev Pandha	2019	97
11	Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis Clinical Cancer Research ·Daniel J. George, Jean-François Martini, Michael Staehler, Robert J. Motzer, Ahmed Magheli, Frede Donskov, Bernard Escudier, Sherry Li, Michelle Casey, Olga Valota, Brigitte Laguerre, Allan J. Pantuck, Hardev Pandha, Anup Patel, Carol S. T. Li, Alain Ravaud	2018	18
12	Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues Science Translational Medicine ·Aadil Khan, James Paget, Martin McLaughlin, Joan Kyula, Michelle Wilkinson, Philip W. Coleman, David Mansfield, Victoria Roulstone, Rohit Seth, Martin Halle, Navita Somaiah, Jessica K.R. Boult, Simon P. Robinson, Hardev Pandha, Richard G. Vile, Alan Melcher, Paul A. Harris, Kevin J. Harrington	2018	17
13	Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors Clinical Cancer Research ·Victoria Roulstone, Khurum Khan, Hardev Pandha, Sarah Rudman, Matt Coffey, George M. Gill, Alan Melcher, Richard G. Vile, Kevin J. Harrington, Johann S. de Bono, James Spicer	2014	42
14	Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies Clinical Cancer Research ·Eleni Karapanagiotou, Victoria Roulstone, Katie Twigger, Alexander Booth, Mary Anne Tanay, Chris Nutting, Kate Newbold, Martin Gore, James Larkin, Konstantinos N. Syrigos, Matt Coffey, Brad Thompson, K.L. Mettinger, Richard G. Vile, Hardev Pandha, Geoff Hall, Alan Melcher, John Chester, Kevin J. Harrington	2012	151
15	Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer Clinical Cancer Research ·Richard Morgan, Д Н Нефедова, A.A. Gorbunova, Michael Bailey, Katya Xiomara Cruz Cespedes, Stephen Langley, Hayley C. Whitaker, David E. Neal, Mohamed Ismail, Andy Corbett, Nicola Annels, Agnieszka Michael, Hardev Pandha	2011	85
16	Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers Clinical Cancer Research ·Kevin J. Harrington, Eleni Karapanagiotou, Victoria Roulstone, Katie Twigger, Christine L. White, Laura Vidal, Danish Inam, Robin Prestwich, Kate Newbold, Merina Ahmed, Khin Thway, Christopher M. Nutting, Matt Coffey, Dean Harris, Richard G. Vile, Hardev Pandha, Johann S. de Bono, Alan Melcher	2010	94
17	Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy Clinical Cancer Research ·Katie Twigger, Laura Vidal, Christine L. White, Johann S. de Bono, Shreerang Bhide, Matt Coffey, Brad Thompson, Richard G. Vile, Lucy Heinemann, Hardev Pandha, Fiona Errington‐Mais, Alan Melcher, Kevin J. Harrington	2008	88
18	Inhibition of Repair of Radiation-Induced DNA Damage Enhances Gene Expression from Replication-Defective Adenoviral Vectors Cancer Research ·Mohan Hingorani, Christine L. White, Chien-Lan Hsueh, Zirwa Javed Dr Meha Siddiqui, Martin Gore, Andrew Slade, Simon D. Scott, Christopher M. Nutting, Hardev Pandha, Alan Melcher, Richard G. Vile, Georges Vassaux, Kevin J. Harrington	2008	20
19	Radiation-Mediated Up-Regulation of Gene Expression from Replication-Defective Adenoviral Vectors: Implications for Sodium Iodide Symporter Gene Therapy Clinical Cancer Research ·Mohan Hingorani, Christine L. White, Shane Zaidi, Chien-Lan Hsueh, Zirwa Javed Dr Meha Siddiqui, Martin Gore, Christopher M. Nutting, Hardev Pandha, Alan Melcher, Richard G. Vile, Georges Vassaux, Kevin J. Harrington	2008	29
20	Antagonism of HOX/PBX Dimer Formation Blocks the In vivo Proliferation of Melanoma Cancer Research ·Richard Morgan, 書絵花輪, 晴香小林, Jastinder Sohal, Ruth Pettengell, Hardev Pandha	2007	83

About Hardev Pandha

Hardev Pandha is a scholar working on Biotechnology, Genetics, Oncology, Immunology and Infectious Diseases, having authored 223 papers that have together received 7.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (95 papers), Cancer Research and Treatments (47 papers), Immunotherapy and Immune Responses (44 papers), CAR-T cell therapy research (43 papers), Viral gastroenteritis research and epidemiology (39 papers), Prostate Cancer Treatment and Research (29 papers), Cancer Immunotherapy and Biomarkers (21 papers) and RNA Interference and Gene Delivery (20 papers). The work is most often cited by research in Genetics (4.0k citations), Oncology (3.6k citations), Biotechnology (1.0k citations), Immunology (1.8k citations) and Infectious Diseases (1.2k citations). Hardev Pandha has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Kevin J. Harrington, Alan Melcher, Richard G. Vile, Richard Morgan, Fiona Errington‐Mais, Matt Coffey, Agnieszka Michael, Peter J. Selby, Robin Prestwich and Jill Thompson. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, Molecular Therapy, BMC Cancer and Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact